Cargando…

Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa

Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Muddassir, Maria, Raza, Almas, Munir, Sadaf, Basirat, Ahmad, Ahmed, Muddassir, Butt, Mazia Shahid, Dar, Omair Arshad, Ahmed, Syed Shoaib, Shamim, Saba, Naqvi, Syed Zeeshan Haider
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712613/
https://www.ncbi.nlm.nih.gov/pubmed/36450765
http://dx.doi.org/10.1038/s41598-022-24531-9
_version_ 1784841825161314304
author Muddassir, Maria
Raza, Almas
Munir, Sadaf
Basirat, Ahmad
Ahmed, Muddassir
Butt, Mazia Shahid
Dar, Omair Arshad
Ahmed, Syed Shoaib
Shamim, Saba
Naqvi, Syed Zeeshan Haider
author_facet Muddassir, Maria
Raza, Almas
Munir, Sadaf
Basirat, Ahmad
Ahmed, Muddassir
Butt, Mazia Shahid
Dar, Omair Arshad
Ahmed, Syed Shoaib
Shamim, Saba
Naqvi, Syed Zeeshan Haider
author_sort Muddassir, Maria
collection PubMed
description Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Kirby-Bauer disc method and PCR were used to study antibiogram and drug resistance genes respectively in 255 isolates of Pseudomonas aeruginosa obtained from a tertiary care hospital. Silver nitrate (AgNO(3)) precursor salts were reacted with Aspergillus flavus culture filtrate to trigger the extracellular mycosynthesis of AgNPs. Mycosynthesis was first monitored regularly by visible ultraviolet spectroscopy that recorded AgNP peaks of approximately 400–470 nm. Confirmation by Transmission electron micrographs provided confirmation of AgNPs formed within a range of 5–30 nm. Individual and combined antibacterial activity of ten antibiotics and AgNPs was analyzed. Pearson correlation coefficients (r) were calculated for phenotypic and genotypic multidrug resistance. Data were evaluated using SPSS version 20. p-value < 0.05 was considered statistically significant. 61.5% were carbapenemase producers (p < 0.01). The recorded frequency of bla(IMP-1), bla(SHV), bla(VIM), bla(OXA), and bla(TEM) were 13%, 32%, 15%, 21%, and 43%, respectively. The reducing order of antimicrobial activity of antibiotics and AgNPs was piperacillin/tazobactam + AgNPs (31 mm), cefoxitin + AgNPs (30 mm) > amikacin + AgNPs (25 mm) > aztreonam + AgNPs (23 mm) > meropenem + AgNPs (22 mm) > imipenem + AgNPs (20 mm) > gentamycin + AgNPs (17 mm) > ciprofloxacin + AgNPs (16 mm) > cefoperazone/sulbactam + AgNPs (14 mm) ≥ ceftazidime + AgNPs (14 mm). The conjugated effect of AgNPs plus antibiotics showed a 0.15–3.51 (average of 2.09) fold-area augmentation of antimicrobial activity. AgNPs conjugated with antibiotics effectively inhibited MDR Pseudomonas aeruginosa. To the best of our understanding, this is an inaugural report from Punjab Pakistan enlisting co-expression of Metallo-β-lactamases, extended-spectrum β-lactamases, and AmpC-β-lactamase plus activity of antibiotic-AgNPs.
format Online
Article
Text
id pubmed-9712613
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97126132022-12-02 Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa Muddassir, Maria Raza, Almas Munir, Sadaf Basirat, Ahmad Ahmed, Muddassir Butt, Mazia Shahid Dar, Omair Arshad Ahmed, Syed Shoaib Shamim, Saba Naqvi, Syed Zeeshan Haider Sci Rep Article Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Kirby-Bauer disc method and PCR were used to study antibiogram and drug resistance genes respectively in 255 isolates of Pseudomonas aeruginosa obtained from a tertiary care hospital. Silver nitrate (AgNO(3)) precursor salts were reacted with Aspergillus flavus culture filtrate to trigger the extracellular mycosynthesis of AgNPs. Mycosynthesis was first monitored regularly by visible ultraviolet spectroscopy that recorded AgNP peaks of approximately 400–470 nm. Confirmation by Transmission electron micrographs provided confirmation of AgNPs formed within a range of 5–30 nm. Individual and combined antibacterial activity of ten antibiotics and AgNPs was analyzed. Pearson correlation coefficients (r) were calculated for phenotypic and genotypic multidrug resistance. Data were evaluated using SPSS version 20. p-value < 0.05 was considered statistically significant. 61.5% were carbapenemase producers (p < 0.01). The recorded frequency of bla(IMP-1), bla(SHV), bla(VIM), bla(OXA), and bla(TEM) were 13%, 32%, 15%, 21%, and 43%, respectively. The reducing order of antimicrobial activity of antibiotics and AgNPs was piperacillin/tazobactam + AgNPs (31 mm), cefoxitin + AgNPs (30 mm) > amikacin + AgNPs (25 mm) > aztreonam + AgNPs (23 mm) > meropenem + AgNPs (22 mm) > imipenem + AgNPs (20 mm) > gentamycin + AgNPs (17 mm) > ciprofloxacin + AgNPs (16 mm) > cefoperazone/sulbactam + AgNPs (14 mm) ≥ ceftazidime + AgNPs (14 mm). The conjugated effect of AgNPs plus antibiotics showed a 0.15–3.51 (average of 2.09) fold-area augmentation of antimicrobial activity. AgNPs conjugated with antibiotics effectively inhibited MDR Pseudomonas aeruginosa. To the best of our understanding, this is an inaugural report from Punjab Pakistan enlisting co-expression of Metallo-β-lactamases, extended-spectrum β-lactamases, and AmpC-β-lactamase plus activity of antibiotic-AgNPs. Nature Publishing Group UK 2022-11-30 /pmc/articles/PMC9712613/ /pubmed/36450765 http://dx.doi.org/10.1038/s41598-022-24531-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Muddassir, Maria
Raza, Almas
Munir, Sadaf
Basirat, Ahmad
Ahmed, Muddassir
Butt, Mazia Shahid
Dar, Omair Arshad
Ahmed, Syed Shoaib
Shamim, Saba
Naqvi, Syed Zeeshan Haider
Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title_full Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title_fullStr Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title_full_unstemmed Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title_short Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
title_sort antibacterial efficacy of silver nanoparticles (agnps) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of pseudomonas aeruginosa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712613/
https://www.ncbi.nlm.nih.gov/pubmed/36450765
http://dx.doi.org/10.1038/s41598-022-24531-9
work_keys_str_mv AT muddassirmaria antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT razaalmas antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT munirsadaf antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT basiratahmad antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT ahmedmuddassir antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT buttmaziashahid antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT daromairarshad antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT ahmedsyedshoaib antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT shamimsaba antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa
AT naqvisyedzeeshanhaider antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa